Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases
Shan Guo, Qi Zhang, Yingjie Guo, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure
Linna Zhao, Juanjuan Zhang, Qiuhang Song, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization
Yigang Hu, Ming Kuang, Hao Song, et al.
European Journal of Pharmacology (2025), pp. 177353-177353
Open Access
Accelerators of chronic hepatitis B fibrosis cirrhosis CCND1 gene expression and promoter hypomethylation
Nan Chen, Pengyu Luo, Yuna Tang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Association between coronary heart disease and risk of advanced liver fibrosis: results of the 2017–2018 national health and nutrition examination survey
Pei Hao, Y. Chen, Fenglan Wu, et al.
European Journal of Gastroenterology & Hepatology (2025)
Closed Access
Immune-endothelial cell crosstalk in hepatic endothelial injury of liver fibrotic mice
Xue Fan, Qianhui Tang, Ninglin Xia, et al.
European Journal of Pharmacology (2025), pp. 177730-177730
Closed Access
CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B
Jingru Song, Lu Liu, Zheng Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28329-e28329
Open Access | Times Cited: 1
Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system
Simer Shera, William Katzka, Julianne C. Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Single-cell profiling of intrahepatic immune cells reveals an expansion of tissue-resident cytotoxic CD4+ T lymphocyte subset associated with pathogenesis of alcoholic-associated liver diseases
Chao Gao, Shiguan Wang, Xiaoyu Xie, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 19, Iss. 2, pp. 101411-101411
Open Access | Times Cited: 1
Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study
Liqun Li, Jing Yan, Qian Liu, et al.
Medicine (2024) Vol. 103, Iss. 36, pp. e39655-e39655
Open Access
Longitudinal transcriptome analysis reveals distinct gene expression patterns in traditional Chinese medicine syndromes of upper respiratory tract infections
Hao Zou, Can Huang, Qinqi Feng, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Artemisitene ameliorates carbon tetrachloride-induced liver fibrosis by inhibiting NLRP3 inflammasome activation and modulating immune responses
Meng-Ke Liu, Juanjuan Tang, Hao Li, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113818-113818
Closed Access
Page 1

Scroll to top